Julian Harrison

Stock Analyst at BTIG

(0)
# 4286
Out of 5,270 analysts
55
Total ratings
32.14%
Success rate
-10.07%
Average return
24 Stocks
Name Action Price Target Current % Upside Ratings Updated
Avalo Therapeutics
Initiates Coverage On: Buy
40
6.69 497.91% 1 Dec 19, 2024
Cartesian Therapeuti...
Initiates Coverage On: Buy
42
17.58 138.91% 1 Dec 19, 2024
Keros Therapeutics
Downgrades: Neutral
n/a
n/a n/a 3 Dec 12, 2024
AnaptysBio
Downgrades: Neutral
n/a
n/a n/a 2 Dec 2, 2024
Outlook Therapeutics
Maintains: Buy
50 9
1.43 529.37% 5 Nov 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
8
1.97 306.09% 4 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
2.37 237.55% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
56 61
14.4 323.61% 3 Sep 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
4.12 264.08% 2 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 25
14.85 68.35% 3 Aug 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
41 51
38.39 32.85% 2 Jul 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
43
7.34 485.83% 1 May 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
32 40
17.88 123.71% 2 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
9.15 129.51% 1 Apr 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 8 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
43
31.4 36.94% 1 Dec 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
4
1.8 122.22% 1 Nov 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
150 150
0.56 26685.71% 1 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
39.7 -9.32% 1 Mar 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
74 181
n/a n/a 3 Dec 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
4
n/a n/a 1 May 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 2 Feb 11, 2022